Abu Dhabi has unveiled a new blood test that can detect over 50 types of cancer early. The Department of Health and Abu Dhabi Public Health Centre launched this Multi-Cancer Early Detection (MCED) test as a major advance in healthcare. The test works like a "liquid biopsy," identifying cancer DNA fragments in blood. It picks up cancers that traditional scans often miss, including pancreatic, liver, and brain cancers. Unlike usual screenings that target one cancer, this test detects many kinds with just one blood sample. It requires no fasting or hospital stay, making it easy to add to regular check-ups. Doctors say it removes many barriers that stop people from getting screened early. The test will be offered mainly to residents aged 40 and above, especially those with a family history of cancer or who missed other screenings. It is available at major clinics run by Ambulatory Healthcare Services and the M42 network across Abu Dhabi city, Al Ain, and Al Dhafra. This test complements standard screenings like mammograms, providing extra cancer detection where no regular tests exist. The cost is between AED 7,000 and AED 8,000. Experts believe the test could save money long-term by catching cancer early, reducing the need for costly treatments. Abu Dhabi’s early adoption highlights its push for data-driven, patient-friendly healthcare. This initiative shows how science, policy, and health systems can unite to fight cancer better. By making early detection easier and more complete, Abu Dhabi is taking a big step towards saving more lives.